Gene · 93
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis by Non-Amplification of Activin A-ACVR2B-NOX4 Axis Pathway. | Adv Sci (Weinh) | 2023 | 36950748 | PubTator, text mining | PubMed |
| Mechanism of skeletal muscle atrophy after spinal cord injury: A narrative review. | Front Nutr | 2023 | 36937344 | PubTator, text mining | PubMed |
| Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children. | Clin Proteomics | 2023 | 36918772 | PubTator, text mining | PubMed |
| Sotatercept analog improves cardiopulmonary remodeling and pulmonary hypertension in experimental left heart failure. | Front Cardiovasc Med | 2023 | 36910526 | PubTator, text mining | PubMed |
| SMAD2/3 signaling in the uterine epithelium controls endometrial cell homeostasis and regeneration. | Commun Biol | 2023 | 36906706 | PubTator, text mining | PubMed |
| Natural Products in Precision Oncology: Plant-Based Small Molecule Inhibitors of Protein Kinases for Cancer Chemoprevention. | Nutrients | 2023 | 36904191 | PubTator, text mining | PubMed |
| Sex Differences in Inflammation and Muscle Wasting in Aging and Disease. | Int J Mol Sci | 2023 | 36902081 | PubTator, text mining | PubMed |
| Myostatin Overexpression and Smad Pathway in Detrusor Derived from Pediatric Patients with End-Stage Lower Urinary Tract Dysfunction. | Int J Mol Sci | 2023 | 36901894 | PubTator, text mining | PubMed |
| Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 36901700 | PubTator, text mining | PubMed |
| Anatomy, embryology, and imaging of situs ambiguous with polysplenia and left IVC. | Radiol Case Rep | 2023 | 36895889 | PubTator, text mining | PubMed |
| Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies. | J Cachexia Sarcopenia Muscle | 2023 | 36864755 | PubTator, text mining | PubMed |
| State- and stimulus-specific dynamics of SMAD signaling determine fate decisions in individual cells. | Proc Natl Acad Sci U S A | 2023 | 36857347 | PubTator, text mining | PubMed |
| Rohitukine content across the geographical distribution of Dysoxylum binectariferum Hook F. and its natural derivatives as potential sources of CDK inhibitors. | Heliyon | 2023 | 36852056 | PubTator, text mining | PubMed |
| Longitudinal Assessment of Creatine Kinase, Creatine/Creatinineratio, and Myostatin as Monitoring Biomarkers in Becker Muscular Dystrophy. | Neurology | 2023 | 36849458 | PubTator, text mining | PubMed |
| Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity. | Metabolites | 2023 | 36837889 | PubTator, text mining | PubMed |
| First Characterization of the Transcriptome of Lung Fibroblasts of SSc Patients and Healthy Donors of African Ancestry. | Int J Mol Sci | 2023 | 36835058 | PubTator, text mining | PubMed |
| Expression and Function of BMP and Activin Membrane-Bound Inhibitor (BAMBI) in Chronic Liver Diseases and Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 36834884 | PubTator, text mining | PubMed |
| Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension. | Int J Mol Sci | 2023 | 36834742 | PubTator, text mining | PubMed |
| Update on Prognostic and Predictive Markers in Mucinous Ovarian Cancer. | Cancers (Basel) | 2023 | 36831515 | PubTator, text mining | PubMed |
| Emerging Mechanisms of Skeletal Muscle Homeostasis and Cachexia: The SUMO Perspective. | Cells | 2023 | 36831310 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/93/papers?page=9